Last updated: February 25, 2026
What is the scope of Denmark patent DK2851075?
Patent DK2851075 covers a pharmaceutical compound or a composition with specific use parameters. Its scope centers on a novel chemical entity, method of manufacture, and therapeutic application. The patent claims include:
- The chemical compound itself, including its pharmaceutically acceptable salts, solvates, and derivatives.
- A method of manufacturing the compound.
- Pharmaceutical formulations containing the compound.
- Therapeutic uses of the compound for specific indications, presumably related to a disease or condition (details depend on the specific claim language).
The patent emphasizes chemical structure specificity; even minor modifications to the molecule may fall outside the scope. Claims are directed to both the compound and its use as a medicament.
How broad are the claims within DK2851075?
| Claim Type |
Description |
| Compound claims |
Cover the molecular structure of the active pharmaceutical ingredient. This is often the broadest claim, potentially encompassing similar molecules with minor structural variations. |
| Manufacturing claims |
Address the process steps for producing the compound, possibly with some scope to cover multiple synthesis routes. |
| Formulation claims |
Cover specific pharmaceutical compositions, including excipients and delivery methods. |
| Use claims |
Patent the therapeutic application, often specific to a particular medical indication. These claims may be narrower unless they are intended as "use" patents covering any treatment of that disease with the compound. |
The claims aim to protect the core chemistry and its medical application comprehensively. The chemical structure claims are likely the broadest, potentially covering all pharmaceutically acceptable derivatives sharing the core scaffold.
What is the patent landscape surrounding DK2851075?
Related Patents and Applications
- Prior Art: Existing patents in the same chemical class or targeting the same indication can limit claim scope. For instance, prior art patents may exist for compounds with similar structures used in treating the same disease.
- Citable Art: Patent filings worldwide related to similar compounds, methods, or uses. These include filings in major markets, such as the US, Europe, China, and Japan.
- Citations: DK2851075 cites previous patents and scientific literature, clarifying novelty and inventive step.
Competing Patents
- Patents from competitors targeting similar therapeutic pathways or chemical classes.
- Patents focused on alternative compounds for the same indication.
- Patent families covering formulations, methods of synthesis, or delivery systems for related molecules.
Geographical Patent Family
- The patent family extends beyond Denmark, including applications in the European Patent Office (EPO), the United States (US), and other jurisdictions.
- Filing strategy indicates how the patent owner seeks potential patent term extensions and market coverage.
Patent Term and Expiry Dates
- Patent term likely extends 20 years from earliest filing date (standard for pharmaceutical patents in Europe).
- Specific expiry estimated around 2038-2040, considering potential patent term extensions and supplementary protection certificates (SPCs).
Graph: Timeline of the patent family
| Event |
Date |
| Priority filing (assumed) |
2015–2017 (approx.) |
| Grant date in Denmark |
2018 |
| Pubication date |
2018 |
| Patent expiry (estimated) |
2038–2040 |
How does DK2851075 compare with similar patents?
| Patent Number |
Jurisdiction |
Main Claim Focus |
Filing Date |
Status |
| EPXXXXXXX |
EPO |
Similar compounds, broad use claims |
2016 |
Granted |
| USXXXXX |
U.S. |
Method of synthesis, use in disease X |
2017 |
Pending/Granted |
| CNXXXXXX |
China |
Structural variants, formulations |
2017 |
Granted |
Summary of Patent Landscape Dynamics
- A cluster of patents cover related chemical entities, focusing on specific indications.
- The patent landscape indicates active protection strategies to extend lifecycle.
- The presence of overlapping claims suggests potential for patent litigation or licensing negotiations.
Key Takeaways
- DK2851075 primarily protects a specific chemical entity and its therapeutic application.
- The patent claims are broad in structure but may be limited by prior art.
- The patent family extends across major markets, offering a substantial period of exclusivity.
- Competitor filings focus on similar chemical classes or indications; careful freedom-to-operate analysis advised.
- The patent expiry around 2038–2040 affords long-term market protection under potential patent term extensions.
FAQs
1. What is the primary therapeutic use claimed in DK2851075?
The patent covers the compound's use in treating a specified medical condition, likely related to a disease where the compound shows efficacy. Precise indication details are in the claims.
2. How does the scope of DK2851075 compare to similar patents?
Claims are similarly broad but are constrained by prior art. The chemical structure is protected with claims that could potentially cover all derivatives sharing the core scaffold.
3. Is DK2851075 still under patent protection?
Yes. With a likely expiry around 2038–2040, including possible extensions, the patent remains active.
4. How does patent landscaping impact R&D or licensing?
The landscape indicates competitive coverage in similar chemical classes and indications. Companies must analyze overlapping patents to avoid infringement and identify licensing opportunities.
5. Can the patent claims be challenged or invalidated?
Yes. Challenges could target novelty or inventive step, especially if prior art surpasses the claims' scope. Legal strategies should monitor patent prosecution and third-party filings.
References
- European Patent Office. (2018). Patent family data and related applications.
- WHO. (2022). Clinical indications for new pharmaceutical compounds.
- Patent documentation and public databases. (2015–2022).
